Published in Epilepsia on May 20, 2013
Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl Stroke Res (2013) 1.06
Potassium channel activator attenuates salicylate-induced cochlear hearing loss potentially ameliorating tinnitus. Front Neurol (2015) 0.75
Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential. Front Physiol (2015) 0.75
Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia (1986) 1.35
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model. Neurology (2007) 1.05
In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models. J Pharmacol Exp Ther (2008) 1.02
Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res (1996) 1.00
New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep (2008) 0.99
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study. Epilepsy Res (2007) 0.93
Photosensitivity as a model for acute antiepileptic drug studies. Electroencephalogr Clin Neurophysiol (1986) 0.91
Preliminary assessment of the efficacy of Org 6370 in photosensitive epileptic patients: paradoxical enhancement of photosensitivity and provocation of myoclonic seizures. Epilepsia (1992) 0.89
A comparison of the acute effect of single doses of vigabatrin and sodium valproate on photosensitivity in epileptic patients. Epilepsy Res (1989) 0.87
Methodology of photic stimulation revisited: updated European algorithm for visual stimulation in the EEG laboratory. Epilepsia (2011) 0.84
Retigabine for partial onset seizures. Expert Rev Neurother (2012) 0.82
De novo mutations in epileptic encephalopathies. Nature (2013) 7.42
ILAE official report: a practical clinical definition of epilepsy. Epilepsia (2014) 7.12
Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol (2007) 2.43
Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology (2012) 2.36
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial. Neurology (2015) 1.84
Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project. Epilepsia (2011) 1.83
Aphasic or amnesic status epilepticus detected on PET but not EEG. Epilepsia (2008) 1.81
Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia (2007) 1.74
Functional MRI predicts post-surgical memory following temporal lobectomy. Brain (2004) 1.71
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia (2013) 1.69
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood (2008) 1.61
Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia (2004) 1.58
Sudden unexpected death in epilepsy: assessing the public health burden. Epilepsia (2014) 1.56
Is refractory epilepsy preventable? Epilepsia (2002) 1.52
Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy. Neurology (2007) 1.52
Is it time to replace the Wada test? Neurology (2002) 1.50
Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav (2010) 1.42
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia (2007) 1.37
Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia (2010) 1.34
The epilepsy phenome/genome project. Clin Trials (2013) 1.32
Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Epilepsia (2013) 1.25
Cross hippocampal influence in mesial temporal lobe epilepsy measured with high temporal resolution functional magnetic resonance imaging. Epilepsia (2011) 1.20
FDG-PET in the diagnosis of complex partial status epilepticus originating from the frontal lobe. Epilepsy Behav (2011) 1.19
Conversions between monotherapies in epilepsy: expert consensus. Epilepsy Behav (2007) 1.17
Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol (2009) 1.13
Functional epileptic network in left mesial temporal lobe epilepsy detected using resting fMRI. Epilepsy Res (2009) 1.13
A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav (2003) 1.09
Resting functional MRI with temporal clustering analysis for localization of epileptic activity without EEG. Neuroimage (2004) 1.08
Lateralization of temporal lobe epilepsy using resting functional magnetic resonance imaging connectivity of hippocampal networks. Epilepsia (2012) 1.05
Seizure diaries for clinical research and practice: limitations and future prospects. Epilepsy Behav (2012) 1.04
Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia (2012) 1.04
In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models. J Pharmacol Exp Ther (2008) 1.02
Development of 2dTCA for the detection of irregular, transient BOLD activity. Hum Brain Mapp (2008) 1.00
Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia (2007) 1.00
Assessment of potential drug interactions in patients with epilepsy: impact of age and sex. Neurology (2009) 0.99
Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy. Clin Neuropharmacol (2005) 0.99
Hippocampal volumetry and functional MRI of memory in temporal lobe epilepsy. Epilepsy Behav (2009) 0.98
Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain (2007) 0.98
Levetiracetam treatment of idiopathic generalised epilepsy. Seizure (2003) 0.97
Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res (2006) 0.96
Neurosyphilis and status epilepticus: case report and literature review. Epilepsy Res (2004) 0.95
Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Epilepsia (2009) 0.95
Functional networks in temporal-lobe epilepsy: a voxel-wise study of resting-state functional connectivity and gray-matter concentration. Brain Connect (2013) 0.94
Resting state functional connectivity of the hippocampus associated with neurocognitive function in left temporal lobe epilepsy. Hum Brain Mapp (2012) 0.94
Cluster analysis detection of functional MRI activity in temporal lobe epilepsy. Epilepsy Res (2007) 0.94
Postmarketing surveillance of new antiepileptic drugs: the tribulations of trials. Epilepsia (2002) 0.94
Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opin Drug Saf (2004) 0.94
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study. Epilepsy Res (2007) 0.93
Evolution of functional connectivity of brain networks and their dynamic interaction in temporal lobe epilepsy. Brain Connect (2014) 0.92
Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions. Lancet Neurol (2012) 0.92
Fear-enhanced visual search persists after amygdala lesions. Neuropsychologia (2010) 0.89
Frontal Localization of Absence Seizures Demonstrated by Ictal Positron Emission Tomography. Epilepsy Behav (2001) 0.89
Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur J Pain (2008) 0.88
Autosomal dominant lateral temporal epilepsy: two families with novel mutations in the LGI1 gene. Epilepsia (2004) 0.88
Patients visiting the emergency room for seizures: insurance status and clinic follow-up. Seizure (2009) 0.87
Rhythmic ictal nonclonic hand (RINCH) motions: a distinct contralateral sign in temporal lobe epilepsy. Epilepsia (2006) 0.87
Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: the subdural hybrid neuroprosthesis. Epilepsy Res Treat (2010) 0.87
Attentional capture by emotional stimuli is preserved in patients with amygdala lesions. Neuropsychologia (2011) 0.87
Epilepsy and the impact of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional setting. Epilepsia (2006) 0.85
In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy. Arch Neurol (2002) 0.85
Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study. AIDS Res Ther (2011) 0.85
Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial. Epilepsia (2014) 0.85
Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial. Epilepsia (2014) 0.85
Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia (2013) 0.85
Issues for new antiepilepsy drug development. Curr Opin Neurol (2013) 0.84
Musicogenic seizures can arise from multiple temporal lobe foci: intracranial EEG analyses of three patients. Epilepsia (2006) 0.84
Enhanced visual cortical activation for emotional stimuli is preserved in patients with unilateral amygdala resection. J Neurosci (2013) 0.83
Self-help cognitive-behavioral therapy with minimal therapist contact for social phobia: a controlled trial. J Behav Ther Exp Psychiatry (2008) 0.83
Is the epilepsy responsive or resistant? Only time will tell. Ann Neurol (2009) 0.83
Childhood febrile status epilepticus: chicken or egg? Does it matter? Neurology (2012) 0.82
Catamenial epilepsy: the elusive condition. Epilepsy Curr (2005) 0.82
Seizure freedom off antiepileptic drugs after temporal lobe epilepsy surgery. Seizure (2007) 0.81
Generalized-onset seizures with secondary focal evolution. Epilepsia (2009) 0.81
Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure (2007) 0.81
Identification of a novel locus for febrile seizures and epilepsy on chromosome 21q22. Epilepsia (2006) 0.80
Tiagabine in clinical practice: effects on seizure control and behavior. Epilepsy Behav (2013) 0.80
Pilomotor seizures: a video case report. Epileptic Disord (2012) 0.80
Febrile seizures: possible outcomes. Neurology (2012) 0.80
Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Care (2009) 0.80
Outpatient pharmacotherapy and modes of administration for acute repetitive and prolonged seizures. CNS Drugs (2015) 0.79
VNS Therapy versus the latest antiepileptic drug. Epileptic Disord (2005) 0.79
A new locus for autosomal dominant generalized epilepsy associated with mild mental retardation on chromosome 3p. Epilepsia (2011) 0.79
Emerging drugs for partial onset seizures. Expert Opin Emerg Drugs (2010) 0.79
Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants. Antimicrob Agents Chemother (2005) 0.79
Posttraumatic stress disorder in a patient with no left amygdala. J Abnorm Psychol (2008) 0.79
Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity. J Med Chem (2003) 0.79
Joint AES/ILAE translational workshop to optimize preclinical epilepsy research. Epilepsia (2013) 0.78
Active control trials for epilepsy: avoiding bias in head-to-head trials. Neurology (2006) 0.78
Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs. Clin Drug Investig (2003) 0.78
Transmeningeal muscimol can prevent focal EEG seizures in the rat neocortex without stopping multineuronal activity in the treated area. Brain Res (2011) 0.78
Overcoming barriers to successful epilepsy management. Epilepsy Curr (2012) 0.78
Comparison of the antiepileptic properties of transmeningeally delivered muscimol, lidocaine, midazolam, pentobarbital and GABA, in rats. Neurosci Lett (2009) 0.78